Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT07245966
Eligibility Criteria:
Inclusion Criteria:
* Participants aging over 18 years old with the symptoms of systemic inflammatory response syndrome (SIRS) which requires at least two of the following symptoms
* Temperature over 38 degree Celsius (Fever) or lower than 36 degree Celsius (hypothermia)
* Tachycardia
* Tachypnea, or the detection of PaCO2 under 32 mmHg, or hypocapnia due to hyperventilation
* Participants are about to received Ceftriaxone by the physician
* Weighting equal to or more than 50 kg
Exclusion Criteria:
* Patients with the clinical record of the severe allergy to β-lactam or Ceftriaxone
* Patients received Ceftriaxone within 3 days before the participation
* Having a culture result of being resistant to Ceftriaxone
* Having CLcr lower than 50 ml/min, or receiving hemodialysis, or renal replacement therapy
* Meningitis patients
* Decompensated liver disease
* Pregnant and lactating
* Septic shock patients
* Having the level of serum albumin lower than 2.5 g/dl
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07245966
Study Brief:
Protocol Section:
NCT07245966